Home > BRISA > Search result
COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 3

Informe diário de evidências COVID-19: busca realizada em 16 de julho de 2020

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde.
Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Betacoronavirus/drug effects, Chloroquine/therapeutic use, Hydroxychloroquine/therapeutic use, Oseltamivir/therapeutic use, Lopinavir/therapeutic use, Ritonavir/therapeutic use, Heparin/therapeutic use, Anti-Bacterial Agents/therapeutic use, Azithromycin/therapeutic use, Ascorbic Acid/therapeutic use, Atorvastatin/therapeutic use, Memantine/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Calcium Channel Blockers/therapeutic use, Enoxaparin/therapeutic use, Meropenem/therapeutic use, Vancomycin/therapeutic use, Adrenal Cortex Hormones/therapeutic use, Interleukin-6/antagonists & inhibitors, Cohort Studies, Cross-Sectional Studies/instrumentation, Technology Assessment, Biomedical
Fulltext

Informe diário de evidências COVID-19: busca realizada entre 1 e 4 de maio de 2020

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde.
Essa é uma produção do Departamento de Ciência e Tecnologia (Decit) da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde (SCTIE) do Ministério da Saúde (Decit/SCTIE/MS), que tem como missão promover a ciência e tecnologia e o uso de evidências científicas para a t...
Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Betacoronavirus/drug effects, Chloroquine/therapeutic use, Hydroxychloroquine/therapeutic use, Vitamin D/therapeutic use, Heparin/therapeutic use, Azithromycin/therapeutic use, Calcium Channel Blockers/therapeutic use, Drug Combinations
Fulltext

Informe de evaluación científica en la evidencia disponible: esclerosis múltiple

Chile. Ministerio de Salud.
INTRODUCCIÓN: Se considerarán para su evaluación aquellas solicitudes realizadas conforme al Reglamento que establece el proceso destinado a determinar los diagnósticos y tratamientos de alto costo con sistema de protección financiera, según lo establecido en los artículos 7° y 8° de la Ley N° ...
Alemtuzumab/therapeutic use, Antibodies, Monoclonal/therapeutic use, Calcium Channel Blockers/therapeutic use, Pyridines/antagonists & inhibitors, Multiple Sclerosis/drug therapy, Technology Assessment, Biomedical, Cost-Benefit Analysis/economics
Fulltext